AdBio Partners

AdBio Partners is a European venture capital firm that invests in early-stage life sciences companies. Their strategy combines early-stage investments with strong entrepreneurial support, aiming to enable and strengthen the growth of their portfolio companies. They proactively source disruptive healthcare innovations from academia and early-stage startups with the potential to change standards of care for patients. They seek out technologies or products coming from research institutions and assist scientists in transforming their research into viable entrepreneurial ventures. The firm acts as a catalyst to create companies based on innovations coming from academic research. They have established relationships with leading research institutions and technology transfer offices in Europe. AdBio Partners provides hands-on expertise, financial resources, and its network to support the executive teams of their portfolio companies in their startup development. They assist their startups in defining development plans and R&D strategy, building commercial visibility, and ensuring the company’s growth at every stage. AdBio Partners emphasizes a hands-on approach, stating they are both entrepreneurs and investors. They believe this strategy enables the early identification of the most promising therapeutic innovations and the ability to kick-start and grow sustainable startups together with scientific founders and academic institutions. They commit to build and grow sustainable life sciences startups to develop tomorrow’s innovation in healthcare. Their core values are anchored in human-led relations, emphasizing high expectations, expertise, curiosity, and humility. They scout, build, and develop life sciences startups from the very early stages.

oncology, immunology, ophthalmology, rare diseases, cardiovascular, renal, metabolic disorders, neuroinflammation

Thematische Schwerpunkte und Zielmarktsegmente von Interesse.